Ocular toxoplasmosis: Evaluation of lacrimal - specific secretory IgA levels in both patients with active and inactive phases of the disease

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 5, 2011, Pages 625-628

  Lynch, Luiz Felipe ^a   Lynch, Maria Isabel ^a   Ferreira, Rodrigo Santana do Nascimento ^a   Vasconcelos, Mirelle Souza Leão ^a   Melo, Narjara ^a   Ferreira, Silvana ^a   Malagueño, Elizabeth ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Ocular toxoplasmosis; Secretory IgA; Tears; Uveitis

Indexed keywords

TOXOPLASMA GONDII;

EID: 80052716554     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000500017     Document Type: Article

References (16)

1. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Woodward JG 1996. Peptide-specific T cell clonal expansion in vivo following immunization in the eye, an immune-privileged site. J Immunol 157: 2262-2271.
2. Garweg JG 2005. Determinants of immunodiagnostic success in human ocular toxoplasmosis. Parasite Immunol 27: 61-68.
3. Garweg JG, Garweg SD, Flueckiger F, Jacquier P, Boehnke M 2004. Aqueous humor and serum immunoblotting for immunoglobulin types G, A, M, and E in cases of human ocular toxoplasmosis. J Clin Microbiol 42: 4593-4598.
4. Gregory RL, Filler SJ 1987. Protective secretory immunoglobulin A antibodies in humans following oral immunization with Streptococcus mutans. Infect Immun 55: 2409-2415.
5. Holland GN 2003. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 136: 973-988.
6. Holland GN 2004. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol 137: 1-17.
7. Knop E, Knop N 2007. Anatomy and immunology of the ocular surface. In JY Niederkorn, HJ Kaplan (eds.), Immune response and the eye, Chemical immunology and allergy, Karger, Basel, p. 36-49.
8. Kodym P, Machala L, Rohácová H, Sirocká B, Malý M 2007. Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis. Clin Microbiol Infect 13: 40-47.
9. Lynch MI, Cordeiro F, Ferreira S, Ximenes R, Oréfice F, Malagueño E 2004. Lacrimal secretory IgA in active posterior uveites induced by Toxoplasma gondii. Mem Inst Oswaldo Cruz 99: 861-864.
10. Lynch MI, Malagueño E, Lynch LF, Ferreira S, Stheling R, Oréfice F 2009. Anti-Toxoplasma gondii secretory IgA in tears of patients with ocular toxoplasmosis: immunodiagnostic validation by ELISA. Mem Inst Oswaldo Cruz 104: 818-822.
11. Lynch MI, Moraes LFL, Malagueño E, Ferreira S, Cordeiro F, Oréfice F 2008. Características clínicas de 64 indivíduos portadores de uveítes posterior activa presumiblemente toxoplásmica en Pernambuco. Arq Bras Oftalmol 71: 43-48.
12. Meek B, Back JW, Klaren VN, Speijer D, Peek R 2002. Conserved regions of protein disulfide isomerase are targeted by natural IgA antibodies in humans. Int Immunol 14: 1291-1301.
13. Meek B, Klaren VN, van Haeringen NJ, Kijlstra A, Peek R 2000. IgA antibodies to Toxoplasma gondii in human tears. Invest Ophthalmol Vis Sci 41: 2584-2590.
14. Meek B, Speijer D, de Jong PT, de Smet MD, Peek R 2003. The ocular humoral immune response in health and disease. Prog Retin Eye Res 22: 391-415.
15. Silveira C, Belfort R Jr, Burnier M Jr, Nussenblatt R 1988. Acquired toxoplasmic infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol 106: 362-364.
16. Stanford MR, Gras L, Wade A, Gilbert RE 2002. Reliability of expert interpretation of retinal photographs for the diagnosis of toxoplasmaretinochoroiditis. Br J Ophthalmol 86: 636-639.